Key statistics
On Friday, Omeros Corp (OMER:NMQ) closed at 3.65, 23.73% above the 52 week low of 2.95 set on Jul 01, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.46 |
---|---|
High | 3.79 |
Low | 3.44 |
Bid | 3.64 |
Offer | 3.75 |
Previous close | 3.46 |
Average volume | 1.06m |
---|---|
Shares outstanding | 58.59m |
Free float | 55.37m |
P/E (TTM) | -- |
Market cap | 213.86m USD |
EPS (TTM) | -3.04 USD |
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
More ▼
- Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA
- Omeros Announces Webcast Details for Annual Meeting of Shareholders
- Omeros Corporation Reports First Quarter 2025 Financial Results
- Omeros Corporation to Announce First Quarter Financial Results on May 15, 2025
- Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026
- FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date
More ▼